Daxx, a Fas-binding protein that activates JNK and apoptosis
US6159731A · kind A · utility
9Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 1998 |
| Grant date | Dec 12, 2000 |
| Priority date | — |
| Expiry date | Feb 12, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention describes nucleic acids encoding the Daxx protein, including fragments and biologically functional variants thereof. Also included are polypeptides and fragments thereof encoded by such nucleic acids, and antibodies relating thereto. Methods and products for using such nucleic acids and polypeptides also are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.